Amazon cover image
Image from Amazon.com

Ethical issues in international biomedical research : a casebook / edited by James V. Lavery ... [et al.].

Contributor(s): Publication details: Oxford ; New York : Oxford University Press, 2007.Description: xxvii, 371 p. ; 24 cmISBN:
  • 0195179226 (alk. paper)
  • 9780195179224 (alk. paper)
Subject(s): NLM classification:
  • W 50 E84 2007
Online resources:
Contents:
Contents INTRODUCTION. PART I: COLLABORATIVE PARTNERSHIP. Case 1. Community involvement in biodiversity prospecting in Mexico. Case 2. Selling genes: consulting a genetic population database in Tonga. Case 3: Substantiality of a fluoride varnish feasability study in Nicaragua. PART II: SCIENTIFIC VALIDITY. Case 4: Malarone testing in pregnant women in Thailand. Case 5: Neglected diseases: Incentives to Conduct Research in Developing Countries: the case of Pharamomycin for visceral leishmaniasis in India. SECTION III: SCIENTIFIC VALIDITY. Case 7. The limitations of knowledge: equipsoise and a randomized treatment strategy for malaria in Ethiopia. Case 8. Controversy surrounding the scientific value of the Vaxgen/Aventis (RV-144) Phase III. PART IV: FAIR SUBJECT AND COMMUNITY SELECTION. Case 9. Pharmaceutical research in developing countries: testing a new sufracant in Bolivia. Case 10: Trading Genes for Toothbrushes: Research with the Aka Pygmy people in the Central African Republic. Case 11: Test Phase I malaria vaccine: where should the research be conducted?. PART V: FAVOURABLE RISK/BENEFIT ASSESSMENT. Case 12: Ethical complcations during an investigation of malaria infection in native Amazonian populations in western Brazil. Case 13: Access to treatment for trial participants who become infected with HIV during the course of Phase I trials of a preventive HIV vaccine in South Africa. PART VI: INDEPENDENT REVIEW. Case 14: How independent is independent review? Partner notification in a study of sexually-transmitted diseases in Mpumalanga, South Africa. Case 15: Which regulations protect subjects best: preventing HIV status disclosure in a community-based circumcision study in rural Uganda. PART VII: INFORMED CONSENT. Case 16: The challenge of informed consent in a genetic epidemiology study of noma in rural Nigeria. Case 17: Compensation to families who consent to research autopsy for their children in a study of malaria mortality in Malawi: respectful or coercive?. PART VIII: RESPECT FOR ENROLLED SUBJECTS AND THEIR COMMUNITIES. Case 18: A randomized trial of low-phytate corn for maternal-infant micronutrient deficiency in Guatemala. Case 19: Obligations to participants harmed in the course of the N-9 multi-centre vaginal microbicide trial in South Africa. Case 20: Ethical challenges and controversy in a retrospective study of HIV-1 transmission in Uganda. Case 21: Protecting subjects in a study of domestic violence in South Africa: what services are researchers obligated to provide?.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Book Open Access Book Open Access Health Sciences Library W 50 E84 2007 (Browse shelf(Opens below)) 1 Available MBAL22050102

Includes bibliographical references and index.

Contents

INTRODUCTION.

PART I: COLLABORATIVE PARTNERSHIP.
Case 1. Community involvement in biodiversity prospecting in Mexico.
Case 2. Selling genes: consulting a genetic population database in Tonga.
Case 3: Substantiality of a fluoride varnish feasability study in Nicaragua.

PART II: SCIENTIFIC VALIDITY.
Case 4: Malarone testing in pregnant women in Thailand.
Case 5: Neglected diseases: Incentives to Conduct Research in Developing Countries: the case of Pharamomycin for visceral leishmaniasis in India.

SECTION III: SCIENTIFIC VALIDITY.
Case 7. The limitations of knowledge: equipsoise and a randomized treatment strategy for malaria in Ethiopia.
Case 8. Controversy surrounding the scientific value of the Vaxgen/Aventis (RV-144) Phase III.

PART IV: FAIR SUBJECT AND COMMUNITY SELECTION.
Case 9. Pharmaceutical research in developing countries: testing a new sufracant in Bolivia.
Case 10: Trading Genes for Toothbrushes: Research with the Aka Pygmy people in the Central African Republic.
Case 11: Test Phase I malaria vaccine: where should the research be conducted?.

PART V: FAVOURABLE RISK/BENEFIT ASSESSMENT.
Case 12: Ethical complcations during an investigation of malaria infection in native Amazonian populations in western Brazil.
Case 13: Access to treatment for trial participants who become infected with HIV during the course of Phase I trials of a preventive HIV vaccine in South Africa.

PART VI: INDEPENDENT REVIEW.
Case 14: How independent is independent review? Partner notification in a study of sexually-transmitted diseases in Mpumalanga, South Africa.
Case 15: Which regulations protect subjects best: preventing HIV status disclosure in a community-based circumcision study in rural Uganda.

PART VII: INFORMED CONSENT.
Case 16: The challenge of informed consent in a genetic epidemiology study of noma in rural Nigeria.
Case 17: Compensation to families who consent to research autopsy for their children in a study of malaria mortality in Malawi: respectful or coercive?.

PART VIII: RESPECT FOR ENROLLED SUBJECTS AND THEIR COMMUNITIES.
Case 18: A randomized trial of low-phytate corn for maternal-infant micronutrient deficiency in Guatemala.
Case 19: Obligations to participants harmed in the course of the N-9 multi-centre vaginal microbicide trial in South Africa.
Case 20: Ethical challenges and controversy in a retrospective study of HIV-1 transmission in Uganda.
Case 21: Protecting subjects in a study of domestic violence in South Africa: what services are researchers obligated to provide?.

There are no comments on this title.

to post a comment.